JPS5583768A - Organic compound - Google Patents

Organic compound

Info

Publication number
JPS5583768A
JPS5583768A JP16289979A JP16289979A JPS5583768A JP S5583768 A JPS5583768 A JP S5583768A JP 16289979 A JP16289979 A JP 16289979A JP 16289979 A JP16289979 A JP 16289979A JP S5583768 A JPS5583768 A JP S5583768A
Authority
JP
Japan
Prior art keywords
organic compound
organic
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP16289979A
Other languages
English (en)
Other versions
JPS639512B2 (ja
Inventor
Antonio Arujierii Arudoo
Rei Kurenshiyou Ronnii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of JPS5583768A publication Critical patent/JPS5583768A/ja
Publication of JPS639512B2 publication Critical patent/JPS639512B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
JP16289979A 1978-12-18 1979-12-17 Organic compound Granted JPS5583768A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/970,517 US4200578A (en) 1978-12-18 1978-12-18 Thiazole derivatives

Publications (2)

Publication Number Publication Date
JPS5583768A true JPS5583768A (en) 1980-06-24
JPS639512B2 JPS639512B2 (ja) 1988-02-29

Family

ID=25517073

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16289979A Granted JPS5583768A (en) 1978-12-18 1979-12-17 Organic compound

Country Status (24)

Country Link
US (1) US4200578A (ja)
JP (1) JPS5583768A (ja)
KR (3) KR830001920B1 (ja)
AT (1) AT375354B (ja)
AU (1) AU533014B2 (ja)
BE (1) BE880662A (ja)
CA (1) CA1133909A (ja)
CH (1) CH642956A5 (ja)
DE (1) DE2950838A1 (ja)
DK (1) DK533979A (ja)
ES (2) ES487035A0 (ja)
FI (1) FI793904A (ja)
FR (1) FR2444674B1 (ja)
GB (1) GB2038822B (ja)
GR (1) GR73586B (ja)
HU (1) HU182461B (ja)
IE (1) IE49320B1 (ja)
IL (1) IL58960A (ja)
IT (1) IT1164076B (ja)
LU (1) LU82000A1 (ja)
NL (1) NL7909054A (ja)
SE (1) SE444680B (ja)
YU (3) YU292179A (ja)
ZA (1) ZA796814B (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5791980A (en) * 1980-10-02 1982-06-08 Lilly Co Eli 2,4-disubstituted thiazole derivatives
JPS58170773A (ja) * 1982-03-19 1983-10-07 イーライ・リリー・アンド・カンパニー チアゾ−ル系抗潰瘍薬
JPS59152378A (ja) * 1983-02-07 1984-08-31 イーライ・リリー・アンド・カンパニー ニザチジン合成法

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE31588E (en) * 1977-06-03 1984-05-22 Bristol-Myers Company Imidazolylmethylthioethyl alkynyl guanidines
GR71929B (ja) * 1979-11-13 1983-08-19 Ici Ltd
US4760075A (en) * 1980-10-02 1988-07-26 Eli Lilly And Company N-thiazolylmethylthioalkyl-N-alkyl-amidines and related compounds
US4382090A (en) * 1980-10-02 1983-05-03 Eli Lilly And Company N-Thiazolylmethylthioalkyl-N'alkylamidines and related compounds
US4904792A (en) * 1980-10-02 1990-02-27 Eli Lilly And Company N-thiazolymethylthioalkyl-N'-alkylamidines and related compounds
NZ202797A (en) * 1981-12-28 1985-08-30 Lilly Co Eli Pyrimidine derivatives and pharmaceutical compositions
US4458077A (en) * 1982-11-22 1984-07-03 American Home Products Corporation Heterocyclic anti-ulcer agents
JPS59104370A (ja) * 1982-12-03 1984-06-16 Kotobuki Seiyaku Kk チアゾ−ル誘導体及びその製造方法
ZA869438B (en) * 1985-12-18 1988-07-27 Lilly Co Eli Synthesis of nizatidine
JPH0247453U (ja) * 1988-09-29 1990-03-30
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer
CN111974333B (zh) * 2020-08-19 2023-06-09 宁夏亚东化工有限公司 噻唑生产线及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758146A (fr) * 1969-10-29 1971-04-28 Smith Kline French Lab Derives de l'amidine
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
BE804144A (en) 1972-09-05 1974-02-28 Smith Kline French Lab H-2-Receptor antihistamines esp gastric acid inhibitors - -N-cyano-N"-(heterocyclyl-alkyl-(thio oxa amino or methylene-alkyl)-guanidines
US4083988A (en) * 1972-09-05 1978-04-11 Smith Kline & French Laboratories Limited Pharmacologically active compounds
GB1421792A (en) 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
GB1553070A (en) 1975-05-21 1979-09-19 Smith Kline French Lab Thiourea guanidine and 1-nitro-2,2-diaminoethylene derivatives
ZA782129B (en) 1977-04-20 1979-03-28 Ici Ltd Hertocyclic derivatives
US4112234A (en) * 1977-08-22 1978-09-05 Bristol-Myers Company Imidazolylmethylthioethyl alkynyl guanidines

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5791980A (en) * 1980-10-02 1982-06-08 Lilly Co Eli 2,4-disubstituted thiazole derivatives
JPH021141B2 (ja) * 1980-10-02 1990-01-10 Lilly Co Eli
JPS58170773A (ja) * 1982-03-19 1983-10-07 イーライ・リリー・アンド・カンパニー チアゾ−ル系抗潰瘍薬
JPS59152378A (ja) * 1983-02-07 1984-08-31 イーライ・リリー・アンド・カンパニー ニザチジン合成法
JPH0576473B2 (ja) * 1983-02-07 1993-10-22 Lilly Co Eli

Also Published As

Publication number Publication date
IT7950977A0 (it) 1979-12-04
NL7909054A (nl) 1980-06-20
FR2444674B1 (fr) 1986-03-28
AU5371679A (en) 1980-06-26
SE7910392L (sv) 1980-06-19
BE880662A (fr) 1980-06-17
IL58960A (en) 1983-06-15
AT375354B (de) 1984-07-25
ZA796814B (en) 1980-11-26
GR73586B (ja) 1984-03-26
ES8101569A1 (es) 1980-12-16
GB2038822A (en) 1980-07-30
ES493718A0 (es) 1981-09-01
IT1164076B (it) 1987-04-08
HU182461B (en) 1984-01-30
JPS639512B2 (ja) 1988-02-29
FR2444674A1 (fr) 1980-07-18
LU82000A1 (de) 1980-07-21
KR840001074B1 (ko) 1984-07-31
IE49320B1 (en) 1985-09-18
KR840001075B1 (ko) 1984-07-31
KR840004685A (ko) 1984-10-22
KR840004686A (ko) 1984-10-22
KR830001920B1 (ko) 1983-09-23
FI793904A (fi) 1980-06-19
CA1133909A (en) 1982-10-19
YU259382A (en) 1983-02-28
SE444680B (sv) 1986-04-28
DE2950838A1 (de) 1980-07-03
US4200578A (en) 1980-04-29
IE792436L (en) 1980-06-18
ATA793779A (de) 1983-12-15
IL58960A0 (en) 1980-03-31
DK533979A (da) 1980-06-19
YU292179A (en) 1983-02-28
AU533014B2 (en) 1983-10-27
YU259482A (en) 1983-02-28
KR830001263A (ko) 1983-04-29
GB2038822B (en) 1983-01-19
CH642956A5 (fr) 1984-05-15
ES8106715A1 (es) 1981-09-01
ES487035A0 (es) 1980-12-16

Similar Documents

Publication Publication Date Title
GB2019873B (en) Organic compounds
JPS54119486A (en) 66substituted thiaaaza compound
JPS55153769A (en) Organic compound
JPS5515461A (en) Organic compound
GB2030169B (en) Organic compounds
GB2026528B (en) Organic compounds
GB2012313B (en) Organic compounds
GB2025999B (en) Bistrialkoxysiloxy - silane compound
JPS5583768A (en) Organic compound
JPS54163582A (en) 22phenoxyy55 trifluoromethypiridine compound
JPS54138524A (en) Boronnsilicon compound
JPS54160397A (en) Antiirhinouiruse compound
JPS54138522A (en) Sulfonateeorganosilanol compound
GB2014175B (en) Organic compounds
GB2013668B (en) Organic compounds
JPS5536471A (en) Spiroketaline compound
JPS54141766A (en) Antiiinflammatory compound
JPS54128538A (en) 44nitroo22trichlormethyllphenyldisulfide compound
JPS55135166A (en) Organic compound
JPS5559193A (en) Bblactam compound
JPS54151972A (en) Organic compound
JPS554400A (en) Hindereddphenol compound
JPS54132574A (en) Organic compound
GB2020683B (en) Organic compounds
JPS54151989A (en) 44pyrimidylsulfide compound